3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
2
Myeloproliferative Disorders
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
von Hippel-Lindau Disease
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pyruvate Kinase Deficiency of Red Cells
1
Neuroendocrine Tumors
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Myelitis, Transverse
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Metastatic Castration-resistant Prostate Cancer
1
Marijuana Abuse
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphedema
1
Locally Advanced Head and Neck Carcinoma
1
Liver Neoplasms
1
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Blood Specimen Collection
×
30 days
×
Clear all
NCT07570407
2026-05-06
QiNKT-HSCT
University Hospital Pilsen
Not yet recruiting
75 enrolled